403 related articles for article (PubMed ID: 23644972)
1. Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): the missing term in the literature.
Peyrin-Biroulet L
Am J Gastroenterol; 2013 May; 108(5):859-60. PubMed ID: 23644972
[No Abstract] [Full Text] [Related]
2. Guidelines for the management of inflammatory bowel disease in adults.
Carter MJ; Lobo AJ; Travis SP;
Gut; 2004 Sep; 53 Suppl 5(Suppl 5):V1-16. PubMed ID: 15306569
[No Abstract] [Full Text] [Related]
3. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
[No Abstract] [Full Text] [Related]
4. Refractory inflammatory bowel disease in children.
Oliva-Hemker M; Escher JC; Moore D; Dubinksy M; Hildebrand H; Koda YK; Murch S; Sandhu B; Seo JK; Tanzi MN; Warner B;
J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):266-72. PubMed ID: 18664886
[No Abstract] [Full Text] [Related]
5. Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
Hanauer SB
Gut; 2007 Sep; 56(9):1181-3. PubMed ID: 17698862
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
[TBL] [Abstract][Full Text] [Related]
7. Anti-TNF therapy in inflammatory bowel diseases: a huge review.
Peyrin-Biroulet L
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):233-43. PubMed ID: 20485259
[TBL] [Abstract][Full Text] [Related]
8. Novel agents in the future: Therapy beyond anti-TNF agents in inflammatory bowel disease.
Peng JC; Shen J; Ran ZH
J Dig Dis; 2014 Nov; 15(11):585-90. PubMed ID: 25251263
[TBL] [Abstract][Full Text] [Related]
9. Infliximab in ulcerative colitis.
Aberra FN; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
[TBL] [Abstract][Full Text] [Related]
10. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
Danese S; Angelucci E
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S217-27. PubMed ID: 20117345
[TBL] [Abstract][Full Text] [Related]
11. [Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis].
Fiasse R; Denis MA; Dewit O
J Pharm Belg; 2010 Mar; (1):1-9. PubMed ID: 20432590
[TBL] [Abstract][Full Text] [Related]
12. [Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficient].
Hellström PM; Schmidt D; Karlén P
Lakartidningen; 2007 Oct 10-16; 104(41):2973-6. PubMed ID: 17977308
[No Abstract] [Full Text] [Related]
13. Anti-TNF-alpha treatment strategies: results and clinical perspectives.
D'Haens G
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S209-16. PubMed ID: 20117344
[TBL] [Abstract][Full Text] [Related]
14. CDP 571. Anti-TNF monoclonal antibody, BAY 103356.
Drugs R D; 1999 Mar; 1(3):253-5. PubMed ID: 10566038
[No Abstract] [Full Text] [Related]
15. [Inflammatory bowel disease: an overview].
Herrlinger K
Med Monatsschr Pharm; 2013 Nov; 36(11):402-8; quiz 409. PubMed ID: 24640117
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-α monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology.
Lee TW; Fedorak RN
Gastroenterol Clin North Am; 2010 Sep; 39(3):543-57. PubMed ID: 20951917
[TBL] [Abstract][Full Text] [Related]
17. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
Rutgeerts P; Van Assche G; Vermeire S
Aliment Pharmacol Ther; 2006 Feb; 23(4):451-63. PubMed ID: 16441465
[TBL] [Abstract][Full Text] [Related]
18. [Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of anti-tumor necrosis factor drugs in inflammatory bowel disease].
Cabriada JL; Vera I; Domènech E; Barreiro-de Acosta M; Esteve M; Gisbert JP; Panés J; Gomollón F;
Gastroenterol Hepatol; 2013 Mar; 36(3):127-46. PubMed ID: 23433780
[No Abstract] [Full Text] [Related]
19. Inflammatory bowel disease: short- and long-term treatments.
Bickston SJ; Cominelli F
Adv Intern Med; 1998; 43():143-74. PubMed ID: 9506181
[No Abstract] [Full Text] [Related]
20. Targeting TNF-α for the treatment of inflammatory bowel disease.
Billiet T; Rutgeerts P; Ferrante M; Van Assche G; Vermeire S
Expert Opin Biol Ther; 2014 Jan; 14(1):75-101. PubMed ID: 24206084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
